Thoughts On “Momenta Sues Teva Over Heparin Patents”
The author neglects to mention that the GAO’s report found no fault with Momenta, whose technology guides was the only one able to identify for the FDA the contaminant in the Chinese Heparin imports that had already caused over 80 deaths in the U.S., nor evidence of actual bias on the part of the FDA. Ironically, the technology that Momenta used to save patients’ lives was the same technology Teva is alleged to have now copied and used to try and meet the FDA’s tough standards for generic Lovenox.
The slant of this story is more evidence of the anti-Momenta, pro-Teva bias in the news media and on Wall Street. Personally, I’m glad to see Momenta finally fighting back against Teva’s posturing and now it appears, illegal copying tactics.
